{"nctId":"NCT04531540","briefTitle":"Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)","startDateStruct":{"date":"2013-09-09","type":"ACTUAL"},"conditions":["Hypersensitivity"],"count":225,"armGroups":[{"label":"Repeated Insult Patch Test","type":"EXPERIMENTAL","interventionNames":["Drug: Butenafine HCl 1% (BAY1896425)"]}],"interventions":[{"name":"Butenafine HCl 1% (BAY1896425)","otherNames":["Antifungal Cream V61-044 containing Trolamine"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects must have been aged 18 to 79 years, inclusive;\n* Female subjects must have produced a negative urine pregnancy test prior to the initiation and also at the completion of the trial;\n* Subjects must have been capable of understanding and following directions.\n\nExclusion Criteria:\n\n* Subjects who were in ill health or taking medication, other than birth control, which could influence the purpose, integrity or outcome of the trial;\n* Subjects who had any visible skin disease that might be confused with a skin reaction to the test material;\n* Subjects who were participating in another clinical trial at this facility or any other facility;\n* Subjects who used topical or systemic steroids or antihistamines for at least 7 days prior to trial initiation and during the duration of the trial;\n* Subjects who had a history of adverse reactions to adhesive tape, cosmetics, OTC drugs or other personal care products;\n* Subjects judged by the PI to be inappropriate for the trial;\n* Female subjects who were pregnant as evidenced by a urine pregnancy test, planning to become pregnant, or nursing during the course of the trial.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"79 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Irritation Response Evaluation According to Erythema Scoring Scale During Induction Phase - All Enrolled Subjects","description":"Prior to each patch application and after the last patch removal, the test sites were evaluated for gross changes according to the Erythema Scoring Scale: score 0=No visible erythema; score 0.5=Slight, barely perceptible erythema; score 1=Mild erythema; score 2=Moderate erythema; score 3=Marked erythema; score 4=Severe erythema.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2182","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]}]},{"type":"PRIMARY","title":"Allergic Reaction Evaluation According to Erythema Scoring Scale During Challenge Phase - All Enrolled Subjects","description":"Prior to each patch application and after the last patch removal, the test sites were evaluated for gross changes according to the Erythema Scoring Scale: score 0=No visible erythema; score 0.5=Slight, barely perceptible erythema; score 1=Mild erythema; score 2=Moderate erythema; score 3=Marked erythema; score 4=Severe erythema.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1296","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Irritation Response Evaluation According to Erythema Scoring Scale During Induction Phase - All Evaluable Subjects","description":"Prior to each patch application and after the last patch removal, the test sites were evaluated for gross changes according to the Erythema Scoring Scale: score 0=No visible erythema; score 0.5=Slight, barely perceptible erythema; score 1=Mild erythema; score 2=Moderate erythema; score 3=Marked erythema; score 4=Severe erythema.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2158","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]}]},{"type":"PRIMARY","title":"Allergic Reaction Evaluation According to Erythema Scoring Scale During Challenge Phase - All Evaluable Subjects","description":"Prior to each patch application and after the last patch removal, the test sites were evaluated for gross changes according to the Erythema Scoring Scale: score 0=No visible erythema; score 0.5=Slight, barely perceptible erythema; score 1=Mild erythema; score 2=Moderate erythema; score 3=Marked erythema; score 4=Severe erythema.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1296","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":225},"commonTop":["Headache","Renal calculi","Enterocolitis infectious","Sinusitis","Urinary Tract Infection"]}}}